Table 3 Correlation between miR-204-5p and 32 predicted lncRNAs in breast cancer analyzed by R.
lncRNA | miRNA | R-value | P-value |
|---|---|---|---|
LINC01929 | hsa-miR-204-5p | − 0.19252 | 1.92E−10*** |
RHPN1-AS1 | hsa-miR-204-5p | − 0.17395 | 9.30E−09*** |
C6orf99 | hsa-miR-204-5p | − 0.14819 | 1.05E−06*** |
LINC01705 | hsa-miR-204-5p | − 0.14134 | 3.25E−06*** |
WT1-AS | hsa-miR-204-5p | − 0.13314 | 1.18E−05*** |
LINC02201 | hsa-miR-204-5p | − 0.11941 | 8.62E−05*** |
AP001434.1 | hsa-miR-204-5p | − 0.11728 | 0.000115*** |
LINC01614 | hsa-miR-204-5p | − 0.11573 | 0.000142*** |
AC129926.2 | hsa-miR-204-5p | − 0.11098 | 0.000265*** |
LINC02257 | hsa-miR-204-5p | − 0.10697 | 0.00044*** |
AC093515.1 | hsa-miR-204-5p | − 0.10536 | 0.000537*** |
AL513123.1 | hsa-miR-204-5p | − 0.09647 | 0.001535** |
AC069061.2 | hsa-miR-204-5p | − 0.0887 | 0.003591** |
KCNMB2-AS1 | hsa-miR-204-5p | − 0.08557 | 0.004971** |
SIRLNT | hsa-miR-204-5p | − 0.08533 | 0.005099** |
AC079160.1 | hsa-miR-204-5p | − 0.08365 | 0.006042** |
AC007128.2 | hsa-miR-204-5p | − 0.08174 | 0.007302** |
AC087591.1 | hsa-miR-204-5p | − 0.07922 | 0.009333** |
AC132807.2 | hsa-miR-204-5p | − 0.07777 | 0.010713* |
AC092448.1 | hsa-miR-204-5p | − 0.07387 | 0.015374* |
AC078983.1 | hsa-miR-204-5p | − 0.0732 | 0.016323* |
AC061975.6 | hsa-miR-204-5p | − 0.07233 | 0.017648* |
AC000067.1 | hsa-miR-204-5p | − 0.0712 | 0.019508* |
AC009686.2 | hsa-miR-204-5p | − 0.07072 | 0.020345* |
AC068189.1 | hsa-miR-204-5p | − 0.07007 | 0.021523* |
LINC01419 | hsa-miR-204-5p | − 0.06961 | 0.022393* |
LINC02726 | hsa-miR-204-5p | − 0.06849 | 0.024659* |
LINC02163 | hsa-miR-204-5p | − 0.06847 | 0.024703* |
AC117945.2 | hsa-miR-204-5p | − 0.06551 | 0.031669* |
LINC01615 | hsa-miR-204-5p | − 0.06531 | 0.032186* |
MIR3150BHG | hsa-miR-204-5p | − 0.0646 | 0.034105* |
AL357033.2 | hsa-miR-204-5p | − 0.0603 | 0.047969* |